Project Details
Description
Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 in Combination with Tremelimumab or Tremelimumab Alone in Subjects with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/15 → 11/30/21 |
Funding
- MEDIMMUNE, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.